Ajanta Pharma Philippines Inc. (AAPI) is a wholly owned subsidiary of Ajanta Pharma Limited; a specialty pharmaceutical company engaged in the development, manufacture, and marketing of premium pharmaceutical products worldwide.
Incorporated on April 11, 2008 and based in Metro Manila, Ajanta Pharma Philippines Inc. has quickly established itself as one of the top 35 pharmaceutical corporations distributing prescription only medicines in the Philippines with the introduction of several new pharmaceutical compounds, unique therapeutically optimized fixed dose pharmaceutical combinations and value branded equivalents. Through its parent, Ajanta Pharma Limited, Ajanta Pharma Philippines Inc. is supported by;
An advanced R&D centre (ADVENT) which employees more than 300 scientists for active pharmaceutical ingredient (API) synthesis and formulation development.
5 state of the art manufacturing facilities (4 for manufacture of finished dosage forms and 1 for API production) with two additional finished dosage form manufacturing facilities under construction.